These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Analysis of maintenance therapy in hospitalized patients with exacerbation of bronchial asthma: a six-year observation]. Sereda VP; Svistov AS Klin Med (Mosk); 2005; 83(12):36-41. PubMed ID: 16502722 [TBL] [Abstract][Full Text] [Related]
5. [A new initiative to inform the patients. Education optimizes asthma therapy]. MMW Fortschr Med; 2002 Oct; 144(41):54-5. PubMed ID: 12474365 [No Abstract] [Full Text] [Related]
6. [Introduction to asthma and chronic obstructive pulmonary disease pharmacoeconomics]. Jahnz-Rózyk K Pol Merkur Lekarski; 2004 May; 16 Suppl 1():5-6, 8. PubMed ID: 15524004 [TBL] [Abstract][Full Text] [Related]
8. [Bronchial asthma and COPD--3 million Germans treated for asthma and COPD]. Pneumologie; 2008 Mar; 62(3):120. PubMed ID: 18370351 [No Abstract] [Full Text] [Related]
9. [Guidelines for diagnosis and therapy of patients with asthma 2005. The most important aspects for adults]. Schultze-Werninghaus G; Kardos P; Berdel D; Buhl R; Criée CP; Gillissen A; Kroegel C; Leupold W; Lindemann H; Magnussen H; Nowak D; Rabe KF; Rolke M; Sitter H; Ukena D; Vogelmeier C; Welte T; Wettengel R; Worth H Med Klin (Munich); 2006 Jan; 101(1):60-4. PubMed ID: 16418815 [No Abstract] [Full Text] [Related]
10. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Peters SP; Ferguson G; Deniz Y; Reisner C Respir Med; 2006 Jul; 100(7):1139-51. PubMed ID: 16713224 [TBL] [Abstract][Full Text] [Related]
11. [How to make easier the treatment of asthma]. Ait-Khaled N Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S76-10S79. PubMed ID: 17127972 [No Abstract] [Full Text] [Related]
12. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Sullivan SD; Turk F Allergy; 2008 Jun; 63(6):670-84. PubMed ID: 18445184 [TBL] [Abstract][Full Text] [Related]
13. Anti-immunoglobulin E therapy with omalizumab for asthma. Hendeles L; Sorkness CA Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Brown R; Turk F; Dale P; Bousquet J Allergy; 2007 Feb; 62(2):149-53. PubMed ID: 17298423 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of asthma in adults]. Schultze-Werninghaus G Z Arztl Fortbild Qualitatssich; 2003 Oct; 97(7):467-74. PubMed ID: 14611141 [TBL] [Abstract][Full Text] [Related]
16. Attacking expenditures for asthma. Smith MD; McGhan WF Bus Health; 1997 Apr; 15(4):67-8, 70. PubMed ID: 10166794 [No Abstract] [Full Text] [Related]
17. [Geographic and economic aspects of inhalation therapy]. Haidl P; Köhler D Pneumologie; 1999 Dec; 53(12):612-6. PubMed ID: 10684240 [No Abstract] [Full Text] [Related]
19. Asthma treatment in Arkansas: improved use of anti-inflammatory drugs benefits patients. Wells C; West D; Golden WE J Ark Med Soc; 2002 Sep; 99(3):84-5. PubMed ID: 12216334 [No Abstract] [Full Text] [Related]
20. Cost-effectiveness analysis of early intervention with budesonide in mild persistent asthma. Sullivan SD; Buxton M; Andersson LF; Lamm CJ; Liljas B; Chen YZ; Pauwels RA; Weiss KB J Allergy Clin Immunol; 2003 Dec; 112(6):1229-36. PubMed ID: 14657888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]